Welcome to our dedicated page for BETA Technologies news (Ticker: BETA), a resource for investors and traders seeking the latest updates and insights on BETA Technologies stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BETA Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BETA Technologies's position in the market.
BETA (NYSE:BETA) priced an upsized initial public offering of 29,852,941 Class A shares at $34.00 per share, with a 30-day underwriter option for up to 4,477,941 additional shares.
The shares are expected to begin trading on the New York Stock Exchange on November 4, 2025 under the ticker BETA, and the offering is expected to close on November 5, 2025, subject to customary closing conditions. Morgan Stanley and Goldman Sachs are lead book-runners; additional book-runners include BofA Securities, Jefferies, TPG Capital BD, Citigroup, Cantor, BTIG and Needham.
